Original Query: ALL
Previous Study | Return to List | Next Study

High Dose Interleukin-2 Followed by Intermittent Low Dose Temozolomide in Patients With Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01124734
Recruitment Status : Active, not recruiting
First Posted : May 17, 2010
Last Update Posted : September 14, 2016
Information provided by (Responsible Party):
Joseph Drabick, Milton S. Hershey Medical Center

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : August 2017
  Estimated Study Completion Date : August 2017